1-47416334-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_012186.3(FOXE3):c.19A>G(p.Met7Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000269 in 1,373,022 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_012186.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FOXE3 | NM_012186.3 | c.19A>G | p.Met7Val | missense_variant | 1/1 | ENST00000335071.4 | |
LINC01389 | NR_126355.1 | n.29-6433T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FOXE3 | ENST00000335071.4 | c.19A>G | p.Met7Val | missense_variant | 1/1 | NM_012186.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000199 AC: 3AN: 150824Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000278 AC: 34AN: 1222198Hom.: 0 Cov.: 31 AF XY: 0.0000267 AC XY: 16AN XY: 600164
GnomAD4 genome AF: 0.0000199 AC: 3AN: 150824Hom.: 0 Cov.: 32 AF XY: 0.0000272 AC XY: 2AN XY: 73524
ClinVar
Submissions by phenotype
Congenital primary aphakia;C1862839:Anterior segment dysgenesis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 25, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1007471). This variant has not been reported in the literature in individuals affected with FOXE3-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.005%). This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 7 of the FOXE3 protein (p.Met7Val). - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 15, 2023 | The p.M7V variant (also known as c.19A>G), located in coding exon 1 of the FOXE3 gene, results from an A to G substitution at nucleotide position 19. The methionine at codon 7 is replaced by valine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at